Stroke Trial, Recruiting (NCT06596551)

Stroke Trial, Recruiting NCT06596551 Sponsor: Nanyang Technological University Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06596551 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 21 years or older
People who are recovering from their first stroke, where the stroke was mild to moderate in severity
People who have been discharged from hospital within the last 3 months
People who have been assessed by a clinician as having the thinking and understanding abilities needed to take part in a research study
People who can communicate in English or Mandarin
People who have one main family caregiver aged 21 or older who can also communicate in English or Mandarin

Who may not be able to join:

People whose stroke has affected their ability to understand or use language (a condition called aphasia)
People who are too unwell to take part
People who have moderate to severe difficulties with memory, thinking, or understanding
People whose main family caregiver does not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +65 6316 8943

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06596551

Sponsor: Nanyang Technological University

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +65 6316 8943

More information: https://clinicaltrials.gov/study/NCT06596551

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 21 years or older
People who are recovering from their first stroke, where the stroke was mild to moderate in severity
People who have been discharged from hospital within the last 3 months
People who have been assessed by a clinician as having the thinking and understanding abilities needed to take part in a research study
People who can communicate in English or Mandarin
People who have one main family caregiver aged 21 or older who can also communicate in English or Mandarin

Who may not be able to join:

People whose stroke has affected their ability to understand or use language (a condition called aphasia)
People who are too unwell to take part
People who have moderate to severe difficulties with memory, thinking, or understanding
People whose main family caregiver does not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nanyang Technological University

Registry

ClinicalTrials.gov

Start date

1 March 2024

Est. completion

1 March 2025

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Change in well-being from baseline (patient); Change in well-being from baseline (caregiver only); Change in post-stroke reintegration from baseline (patient only); Change in caregiver burden from baseline (caregiver only); Change in self-efficacy from baseline (patient only)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov